Pennington Partners & Co’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$419K Buy
2,866
+121
+4% +$16.7K 0.13% 87
2026
Q2
$355K Buy
2,745
+117
+4% +$13.7K 0.11% 99
2026
Q1
$318K Buy
2,628
+270
+11% +$31.2K 0.11% 91
2025
Q4
$250K Buy
+2,358
New +$221K 0.1% 82
2025
Q2
– Sell
-2,511
Closed -$227K – 87
2025
Q1
$227K Sell
2,511
-932
-27% -$87K 0.13% 70
2024
Q4
$345K Buy
+3,443
New +$355K 0.17% 61

Other funds holding MRK

Pennington Partners & Co's MRK Position: Q3 2026 in Review

Pennington Partners & Co increased its Merck (MRK) stake by 4.4% in Q3 2026, buying an estimated $16.7K and bringing the position to 2,866 shares worth $419K. The position accounts for 0.13% of the portfolio, ranked #87.

Pennington Partners & Co first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,935 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Pennington Partners & Co held 2,866 shares of Merck worth $419K as of Q3 2026.
  • Pennington Partners & Co bought 121 Merck shares in Q3 2026, an estimated $16.7K.
  • Merck made up 0.13% of Pennington Partners & Co's portfolio in Q3 2026, its #87 holding.
  • Pennington Partners & Co first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,935 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Pennington Partners & Co's 13F filing for Q3 2026, filed 13 Nov 2026.